Rohini Chaudhari

  • Respiratory Infectious Disease Diagnostics Market

    Respiratory Infectious Disease Diagnostics Market: Introduction

    • Respiratory infections are caused by virus, bacteria, and other microbes, which further infect the respiratory system including the lungs, throat, and airways. Spread of infections is often through mucus and saliva that is usually expelled when the person sneezes, coughs, or laughs. Few of the germs are also spread though droplets that spread through air and also spread through travelling, which causes respiratory infections. Furthermore, some people can be infected by touching the remaining microbes on the surface, or touching contaminated hands. Various respiratory infectious diseases include Coronavirus diseases (COVID-19), Middle East Respiratory Syndrome (MERS), severe acute respiratory syndrome (SARS), pneumonia, influenza diseases, tuberculosis, whooping cough (Pertussis), enterobius, and chronic obstructive pulmonary disease (COPD).
    • Recent pandemic resulting into widespread COVID 19 infections across the globe is a major factor that is estimated to boost the demand for diagnosis during forecast period. As per current statistics, in April 2020, 6.08 million people across globe were infected with COVID 19 diseases, and this is likely to impact the need for rapid diagnostics testing. is likely to boost the respiratory infectious diagnostics market during forecast period.

    Planning To Lay Down Future Strategy? Request Brochure Of Respiratory Infectious Disease Diagnostics Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=77737

    Key Drivers and Restraints of Global Respiratory Infectious Disease Diagnostics Market

    • Rise in prevalence of respiratory infectious diseases, such as Coronavirus diseases, MERS, chronic obstructive pulmonary disease, tuberculosis, pertussis, and influenza, is projected to drive the global respiratory infectious disease diagnostics market. According to data published in January 2020, 2519 laboratory-con?rmed cases of Middle East respiratory syndrome (MERS), were reported, which includes 866 associated deaths globally. Majority of cases reported were from Saudi Arabia (2121 cases), including 788 related deaths with a higher fatality rate of 37.1%. Moreover, the emergence of COVID-19 pandemic has driven the demand for faster diagnosis. According to statistics, in May 2020, there were around 6.08 million COVID-19 cases reported globally, which boosts the need for early diagnosis of diseases.
    • Rapid rise in burden of chronic obstructive pulmonary disorders such as chronic bronchitis, emphysema, asthma, and other lung diseases such as tuberculosis, pneumonia, is estimated to boost the respiratory infectious disease diagnostics market. Furthermore, rising lower respiratory infectious disease drives the need for early detection, which further drivers the demand for diagnostics tests.

    To Obtain All-Inclusive Information On Forecast Analysis Of Respiratory Infectious Disease Diagnostics Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=77737

    North America to Lead Global Respiratory Infectious Disease Diagnostics Market

    • In terms of region, the global respiratory infectious disease diagnostics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
    • North America is projected to dominate the global respiratory infectious disease diagnostics market during the forecast period due to an increase in burden of COVID-19, well-developed health care infrastructure, and increasing prevalence of chronic obstructive pulmonary diseases, flu diseases, whooping cough, and other respiratory infections. Adoption of rapid diagnostics tests for faster diagnosis of respiratory infectious diseases is another key factor that is anticipated to augment the respiratory infectious disease diagnostics market in the region. As per CDC statistics, in May 2020, the Real-Time Reverse Transcriptase (RT)-PCR Diagnostic Panel is efficient in detecting the SARS-CoV-2 virus in respiratory specimens. The USFDA also offered its Emergency Use Authorization (EUA) for this test in February 2020.
    • Europe was the second-largest market for respiratory infectious diseases followed by Asia Pacific, owing to the rising prevalence of COPD disease in the region. For instance, according to the European Respiratory Nurses Association (ERNA), 259,000 people die of COPD each year in the EU. Moreover, rising cases of COVID 19 in Italy, Spain, the U.K. and other countries across Europe is boosting the need for diagnosis of respiratory infectious diseases across the region. In Feb 2020, with respect to rising COVID diseases, the molecular diagnostics tests, serology tests, and antigen tests have been approved for faster diagnosis of the COVID 19 disease. This is anticipated to boost the market in the region

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=77737

    Key Players Operating in Global Respiratory Infectious Disease Diagnostics Market

    The global respiratory infectious disease diagnostics market is fragmented, owing to the presence of a large and small number of players. Major players operating in the global respiratory infectious disease diagnostics market are:.

    Global Respiratory Infectious Disease Diagnostics Market: Research Scope

    Global Respiratory Infectious Disease Diagnostics Market, by Disease Type

    • Coronavirus Infections
    • Middle East Respiratory Syndrome (MERS)Pneumonia
    • Influenza diseases
    • Tuberculosis
    • Whooping Cough (Pertussis)
    • Enterovirus
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Others

    More Trending Reports by Transparency Market Research –

    Ileostomy Market -

    https://www.prnewswire.com/news-releases/ileostomy-market-to-reach-an-evaluation-of-us1-65-billion-by-2024--says-tmr-300809103.html

    Menopausal Hot Flashes Market -

    https://www.biospace.com/article/menopausal-hot-flashes-market-treatment-options-targeting-brain-s-thermostat-lead-to-innovations-in-non-hormonal-drugs/


  • Thyroid Gland Disorders Treatment Market Estimated to Expand at a Robust CAGR by 2025

    The global thyroid gland disorder treatment market represents a highly competitive and fragmented landscape. This is mainly due to the presence of numerous small and large players in the market, says Transparency Market Research.

    Some of prominent players operating in the global thyroid gland disorder marker are Abbott, Pfizer, GlaxoSmithKline, Mylan N.V., and Amgen. These players are relying on several strategies such as partnership agreements, regional expansions, brand awareness activities, and increase product profiliration in order to gain a competitive edge in the market. In addition, increasing FDA approval of novel drug patent for the treatment of thyroid gland disorder treatment market is expected to fuel rivalry among players in the coming years.

    Planning To Lay Down Future Strategy? Request Brochure Of Thyroid Gland Disorders Treatment Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3113

    In june 2018, Hutchison China MediTech Limited, a key players in the global throid gland disorder treatment market has initiated a Phase Ib/II proof-of-concept study of sulfatinib in pancreatic neuroendocrine. Once developed and successfully tested the drug is expected to treat tumors and biliary tract cancer efficiently. This is expected to fuel tyroid gland disorder market in the coming years.

    In the same year, another player called AmpliPhi Biosciences Corporation presented a AB-PA01 Bacteriophage Therap. As per the company it is helpful in treating patient with cystic fibrosis.

    According to TMR, the global thyroid gland disorders treatment market was noted at a valuation of US$1,954.7 mn in 2016. The market is expected to rise at a steady 3.3% CAGR from 2017 to 2025. Rising at this CAGR, the global thyroid gland disorder treatment market is expected to hit a valuation of US$2,609.9 mn by 2025.

    To Obtain All-Inclusive Information On Forecast Analysis Of Thyroid Gland Disorders Treatment Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=3113

    On the basis of geography, North America is anticipated to dominate the global thyroid gland disorder treatment market during the forecast period. This can be attributed by the fact higher investments in research and development of novel drugs and equipment for treatment of chronic disorders. Along with this, early adoption of advanced healthcare technologies, rising awareness and increasing geriatric populations are some of the predominant factors expected to drive the global thyroid gland disorder treatment market in the coming years. Based on disorder, the Hypothyroidism segment is expected to lead the global throid gland disorder treatment market in the forecast period.

    Side Effects of Thyroid Gland Disorder Treatment Drugs to Impede Growth

    The global thyroid gland disorder treatment market is anticipated to garner a stready growth during the forecast period. Key factor contributing the growth of thyroid gland disorder treatment market include market include increasing prevalence of thyroid gland disorder, surge in geriatric people, rise in awareness programs by private and public body.

    However, side effects of thyroid gland disorder treatment drugs, habit forming nature and stringent government regulations regarding the sales of medicines are some of the factors expected to hamper growth in the global thyroid gland disorder treatment market. In addition to this asymptomatic nature of thyroid gland disorder is one factor impeding growth in the thyroid gland disorder treatment market. This is because several thyroid gland disorder cases left untreated owing to poor diagnostic.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=3113

    Unprecedented Rise in Alcohol and Tobacco Consumptions to Drive Growth

    Nevertheless, increasing cases of iodine deficiency across the globe is a strong factor expected to propel the growth in the global thyroid gland disorder treatment market.

    Moreover, rise in alcohol and tobacco consumption also leads the thyroid disorders. This is because they contain thiocyanate, a compound responsible to degrade thyroid functioning. This is also expected to open several opportunities for growth of the global thyroid gland disorder treatment market.

    More Trending Reports by Transparency Market Research –

    Spinal Trauma Devices Market –

    https://www.prnewswire.com/news-releases/spinal-trauma-devices-market-to-touch-us4-7-billion-by-2023–says-tmr-300819355.html

    Read our Case study at

    https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up


  • Catheters Market Pegged for Robust Expansion by 2025

    The vendor landscape in the global catheters market is characterized by high degree of consolidation: a few companies with technological expertise and financial might have established their dominance. Several of them have ramped up their investments to reinforce some of the aggressive branding moves. Financial might has also helped them not let their funding flows to dry up in research and development, helping them meet strict requirements in testing, production, and design. This has also caused to elevate the barrier to entry. They have also been stressing on improving the outcomes by improving the design parameters. Manufacturers are also trying to address the patient concerns while improvising on designs.

    Some of the well-entrenched players in the global catheters market are Cook Group, Teleflex Incorporated, Johnson & Johnson, Boston Scientific, C.R. Bard Inc., Medtronic Plc., and B. Barun Melsungen AG.

    Planning To Lay Down Future Strategy? Request Brochure Of Catheters Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=109

    In coming years during the forecast period, the focus on constant material and technological advancement is expected to define the contours of competition in the catheters market. Top contenders for unveiling innovative catheters are testing new elastomer materials that have several mechanical properties to meet the end-user demand.

    Health Burden of Cardiovascular Diseases Drive Demand for Catheterization Techniques

    Opportunities in the global catheters market have thrived mainly on the sales of intravenous medical devices and vascular access devices. Their uptake in the health care industry has been rising due to the use of catheters in a wide range of diagnostic and therapeutic applications.

    The global catheters market is expected to garner CAGR of 7.4% from 2017 to 2025. By 2025 end, the valuation is expected to reach US$55,985.1 million.

    Among the various product types, cardiovascular catheters are expected to contribute the dominant share in global catheters market. In the light of high mortality and health burden of cardiovascular diseases, the drive for use of cardiovascular catheters among patient population has risen. Rising incidence of urinary tract procedures is bolstering growth in the catheters market.

    To Obtain All-Inclusive Information On Forecast Analysis Of Catheters Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=109

    Both ambulatory services and hospitals are witnessing the rise in uptake of intravenous access devices, spurring revenue growth in the catheters market. Advancements in cardiac catheterization techniques have helped expand the popularity of new technologies in catheters in these healthcare settings. These technologies focus on minimizing the risk of catheter-associated risks. Rapid advances have also been made in urinary catheters, unlocking new prospects in the catheters market.

    Adoption of Cutting-Edge Intravenous Medical Devices Account for Opportunities in North America

    Of all the regional markets, North America holds the major share. Europe is one of the prominent regions for revenue generation in the catheters market. Both key regional markets have seen the rapid uptake of advanced catheterization technologies. Adoption of cutting-edge intravenous medical devices and vascular access devices in healthcare systems has spurred revenue in the catheter market.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=109

    On the other hand, Asia Pacific is expected to offer substantial, consistent revenues in the catheters market. Rise in medical tourism has spurred opportunities in the regional market. Rising elderly population in numerous countries has bolstered the demand for minimally invasive medical technologies. This has spurred the demand for new technologies in the catheter market. Furthermore, growing efforts of governments to reduce the hospital expenses has also propelled the uptake of catheterization procedures for urinary and cardiac conditions. Rising incidence of cardiovascular treatments is expected to boost the market.

    The study presented here is based on a report by Transparency Market Research (TMR) titled “Catheters Market (Product type – Cardiovascular catheters, Urology catheters, Intravenous Catheters, Neurovascular catheters, and Specialty catheters; End Users – Hospitals, Ambulatory Surgical Centers, and Dialysis Clinics) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017 – 2025”

    More Trending Reports by Transparency Market Research –

    Oligonucleotide Synthesis Market –

    https://www.globenewswire.com/news-release/2019/02/08/1714081/0/en/Oligonucleotide-Synthesis-Market-to-Reach-Worth-of-US-4-189-Bn-by-2025-owing-to-Rapidly-Growing-Biotechnology-Sectors-TMR.html

    Read our Case study at

    https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up


  • Physician Dispensed Cosmeceuticals Market to Register Substantial Expansion by 2026

     

    Transparency Market Research (TMR) has published a new report titled, “Physician Dispensed Cosmeceuticals Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global physician dispensed cosmeceuticals market was valued at US$ 14,311.52 Mn in 2018. It is projected to expand at a CAGR of 10.3% during forecast period. The global physician dispensed cosmeceuticals market is anticipated to be driven by factors such as emphasis on beauty and appearance, rising awareness about anti-aging, and assurance about safety and efficacy of physician-dispensed cosmeceuticals. The physician dispensed cosmeceuticals market in Asia Pacific is expected to expand at a high CAGR of 12.0% due to changes in lifestyle and cultural attitudes, increasing pollution levels, and potential high consumer base. The region has witnessed increase in purchasing power and better exposure to international brands.

    Planning To Lay Down Future Strategy? Request Brochure Of Physician Dispensed Cosmeceuticals Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=565

    Increasing demand for cosmeceuticals

    Physician dispensed cosmeceuticals include medicated esthetic products that are referred by dermatologists, trichologists, cosmetic surgeons, and allied medical professionals. These products are dispensed at skin and hair clinics, beauty and wellness centers, and are available as OTC products through selected retail outlets. Increasing levels of stress, pollution, and climate change can cause damage to the skin, hair, and eyes. This has created a demand for cosmetic products to treat a wide range of dermatological conditions. Cosmeceutical companies, therefore, are developing newer and advanced cosmeceuticals to target these medical conditions. Consistent demand for advancements in skin care and beauty products is leading to exciting new entries of various products in the physician dispensed cosmeceuticals market.

    To Obtain All-Inclusive Information On Forecast Analysis Of Physician Dispensed Cosmeceuticals Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=565

    Entry of new players in the market

    Various locally based cosmetic professional startups specializing in the manufacture and marketing of cosmeceuticals owned by dermatologists have recently entered the physician dispensed cosmeceuticals market in order to cater to the demand for cosmeceuticals among the local population. New entrants in the cosmeceuticals industry from developing countries include ZO Skin Health, Inc. (Japan), CU SKIN Co., Ltd. (Korea), Dr. Batra’s Skin & Hair Clinic, VLCC, and Kaya Skin Clinic (India). Hence, newer and advanced products are anticipated to enter the physician dispensed cosmeceuticals market in the next few years. Emergence of new concept of herbal medicine is paving the way for the demand for organic physician dispensed cosmeceuticals. These factors drive the global physician dispensed cosmeceutical market.

    The global physician dispensed cosmeceuticals market has been segmented based on product type and region. Furthermore, in terms of product type, the market has been divided into skin care products, hair care products, eye care products, injectable Botox, and others. The skin care products segment accounted for a major share of the global physician dispensed cosmeceuticals market in 2017, as the nature of cosmeceuticals demanded by consumers is largely to treat dermatological conditions. Increasing awareness about personal appearance among the geriatric population and changing attitudes of middle-aged and geriatric populations in developing countries have fueled the demand for cosmeceuticals in order to eliminate the outward signs of aging. The anti-aging segment is expected to maintain its dominance of the market during the forecast period. Similarly, dermal fillers and injectable Botox segments are expected to expand from 2018 to 2026.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=565

    Huge consumer base in Asia Pacific to create opportunities in market

    In terms of region, the global physician dispensed cosmeceuticals market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is mature and technically developed, as compared to the other regions. Hence, the region accounted for a prominent share of the market, in terms of revenue, in 2017. Europe is anticipated to account for a significant share of the global market between 2018 and 2026. Surge in awareness among consumers about cosmeceuticals is expected to fuel the market in the region during the forecast period. The market in Asia Pacific is likely to expand considerably during the forecast period. Increasing preference to retain beauty and youthful appearance drives the demand for effective cosmeceuticals. These factors are expected to propel the demand for cosmeceuticals in this region. Moreover, increasing focus of key players on expansion in Asia Pacific, huge consumer base in the region, and rising awareness drive the physician dispensed cosmeceuticals market in Asia Pacific.

    Key players profiled in this report are Allergan plc, Jan Marini Skin Research, Inc., Johnson & Johnson, L’Oreal S.A., Procter & Gamble Co., Bausch Health Companies Inc., Unilever plc, and ZO Skin Health Inc. Companies operating in the global physician dispensed cosmeceuticals market focus on development and launch of new cosmeceutical products in emerging markets such as Asia Pacific and Latin America.

    More Trending Reports by Transparency Market Research –

    Spinal Trauma Devices Market –

    https://www.prnewswire.com/news-releases/spinal-trauma-devices-market-to-touch-us4-7-billion-by-2023–says-tmr-300819355.html

    Depression Drugs Market –

    https://www.biospace.com/article/depression-drugs-market-middle-east-and-africa-to-offer-significant-incremental-opportunity-tmr/


  • Oligonucleotide Synthesis Market to Reflect Impressive Growth Rate by 2025

    The oligonucleotide synthesis market has been experiencing humungous growth across the forecast period of 2017-2025 primarily due to an increase in the research and development activities and speedy FDA approvals in terms of oligonucleotide-based therapies. The biotechnology and pharmaceutical sectors are on a consistent mission of searching alternatives for the treatment of various diseases. This aspect is boosting the oligonucleotide synthesis market to a great extent as they offer cures and treatments at a relatively low-cost as compared to others. High investments in healthcare and life-science related research programs also assist in increasing the growth rate of the oligonucleotide synthesis market.

    Planning To Lay Down Future Strategy? Request Brochure Of Oligonucleotide Synthesis Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11804

    As per the report by Transparency Market Research, the global oligonucleotide synthesis market will display11.2 percent CAGR across the forecast period from 2017 to 2025 and will expand from a value of US$1.65 bn in 2016 to US $4.189 bn by 2025.

    Speedy Regulatory Approvals and Increasing Investments to Propel Growth Prospects

    Consistent research is undertaken by manufacturers in the oligonucleotide synthesis market and various researchers across the globe to enable the discovery of new drug treatment and vaccines frequently. Investment in the oligonucleotide synthesis market through funding will likely gain traction throughout the forecast period. Collaborations between the government and private companies for the development of academic and research infrastructure are also garnering considerable momentum. Novel approaches for curing chronic conditions through genetic medicines are anticipated to accelerate the growth rate of the oligonucleotide synthesis market.

    Key players of the oligonucleotide synthesis market are involved in mergers and acquisitions frequently. The acquisition of Gene Works by Integrated DNA technologies is a classic instance.

    To Obtain All-Inclusive Information On Forecast Analysis Of Oligonucleotide Synthesis Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=11804

    COVID-19 Diagnosis Demand Creating Positive Growth Influence across Oligonucleotide Synthesis Market

    Expanding the adoption of PCR technologies across the research and diagnostic sector and the use of oligonucleotide synthesis in polymerase chain reaction (PCR) are expected to surge in the forecast period as PCR is a quick COVID-19 detection method. The advent of PCR has brought unprecedented changes to the COVID-19 testing scenario. It has significantly reduced the time required for results. As reverse transcription polymerase chain reaction (RT-PCR) testing has also become the gold standard for COVID-19 testing, the oligonucleotide synthesis market expects to grow at a rapid rate. Integrated DNA Technology (IDT) has already shipped customized oligonucleotide primers and probes which will help to facilitate more accurate detection of SARS-CoV-2. Speeding up COVID-19 tests is also proving to be a growth generator for the oligonucleotide synthesis market. According to the Government of India officials, over 1 million RT-PCR tests are conducted and it plans to increase the rate of testing further.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=11804

    North America to Emerge a Leader in Terms of Growth

    Geographically spread across North America, Latin America, the Middle East and Africa, Asia Pacific, and Europe, the oligonucleotide synthesis market is expected to create ripples across North America. The prime factors for a surge in growth across the forecast period are growing application of companies applying oligonucleotides in therapeutics and a large number of COVID-19 infections across the U.S.A. The stronghold of North America over genomics, oncology, proteomics, drug discovery, and diagnostic screening is also a vital aspect for recording exponential growth throughout the forecast period.

    Asia Pacific also expects substantial growth across the forecast period as the Association of Southeast Asian Nations (ASEAN). China is experiencing a boost in the demand for genetic sequencing mainly due to the rapidly aging population and expanding healthcare system. Encouraging initiatives are also assisting the growth rate of the oligonucleotide synthesis market. For instance, the Chinese Academy of Sciences launched a $9.2 bn project called Precision Medicine Initiative with an aim to sequence over 100 million human genomes by 2030.

    More Trending Reports by Transparency Market Research –

    Viral Vector & Plasmid DNA Manufacturing Market –

    https://www.prnewswire.com/news-releases/global-viral-vector–plasmid-dna-manufacturing-market-to-chart-23-3-cagr-from-2019-to-2027-transparency-market-research-301000176.html

    Urinary Catheters Market –

    https://www.biospace.com/article/urinary-catheters-market-increasing-urinary-incontinence-to-accelerate-market-growth/


  • Genomics Personalized Health Market to Receive Overwhelming Hike in Revenues by 2024

    The global genomics personalized health market is anticpated to be highly fragmented due to presence of large number of palyers in the regional and global market. Some of the key players in the industry are Thermo Fisher Scientific, Inc., QIAGEN, Illumina, Inc., Bio-Rad Laboratories, Inc., Lonza Group, F. Hoffmann-La Roche AG, INVITAE Corporation, Interleukin Genetics Inc., Genetic Technologies Limited, Eastern Biotech and Life Sciences, uBiome, Inc., DNA Genotek Inc. which is a subsidiary of OraSure Technologies, Inc., and XCode Life Sciences Private Limited. In 2016, among these the 4 top players –Thermofisher Scientific, QIAGEN, Illumina Inc., and F. Hoffman-La Roche Ltd. accounted for around 65% of the overall market. Apart from these, the market is also likely to witness a strong competition among the other players to bag more amount of market share. Major players are getting involved in investment in research and development activities so as to come up with a newer technologies and solutions.

    According to a recent report by Transparency Market Research (TMR), the global genomics personalized health market is prognosticated to expand at a robust CAGR of 14.9% during the forecast period from 2017 to 2025. In 2016, the market was valued around worth of US$7,243.0 mn, which is likely to reach around worth of US$25,112.5 mn, by 2025.

    Planning To Lay Down Future Strategy? Request Brochure Of Genomics Personalized Health Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12197

    genomics personalized health market is categorized into diagnostic centers, academics and research institutes, and so on. Among these, as evaluated in 2016, the academics and research centers and diagnostic institutes are the two key shareholders in the global genomics personalized health market, with a collective share of near about 88.0%. On the basis of geography, the North America region’s genomics personalized health market held the maximum number of share all over the world, back in 2016. The region was trailed by Europe. This is because of rise in awareness and growth in healthcare expenses in the region.

    Advancement in Molecular Biology to Boost Market Demand

    The major factor driving the demand in global genomics personalized health market is rise in investment regarding research and development of biomarkers. Biomarkers play a vital role in identifying the physiological condition of person diagnosed with particular disease. So, the rise in number of people suffering from chronic ailments for example, tumor and diabetes have propelled the demand for diagnosis of the illnesses that in turn is contributing in the growth of genomics personalized health market.

    To Obtain All-Inclusive Information On Forecast Analysis Of Genomics Personalized Health Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=12197

    Besides, the advancement in pharmaceutical industry, along with efficient diagnosis and monitoring of the response to the disease treatment are also supporting the rise in demand for genomics personalized health solutions, across the globe. Moreover, significant advancement in molecular biology along with advancement in technology are also fueling the growth in genomics personalized health market. Not to forget, the notable rise in elderly population globally, which require personalized healthcare and medicine is another major factor contributing in market grwoth in forthcoming years.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=12197

    Improper Reimbursement Policies to Hinder Market Growth

    However, there are certain restraining factors hampering the market growth, such as complex regulatory system, contributes in delaying the approval of new technique, is a major hindrance to the amrket development. Additionally, inadequate reimbursement policies is another factor preventing the market to reach its full potential in upcoming years. This factor is more prevalent in developing phase.

    More Trending Reports by Transparency Market Research –

    ePharmacy Market –

    https://www.prnewswire.co.uk/news-releases/improving-internet-access-facilitating-online-drug-sales-driving-epharmacy-market-at-12-3-cagr-transparency-market-research-818764341.html

    Read our Case study at

    https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up


  • Medical Image Analysis Software Market Poised to Expand at a Robust Pace by 2027

    The global medical imaging analysis software market is expanding at a respectable pace in recent times. The healthcare industry is embracing digital technologies at a stellar pace, and has made substantial investments in improving the digital framework. It is evident that the shift from a loosely digitized healthcare sector to a framework with cutting-edge medical technologies would require substantial investments. The entities operating in the global medical imaging analysis software market can capitalise on the availability of affluent investors. Furthermore, the use medical imaging has become an indispensable part of several domains within healthcare and medicine.

    Planning To Lay Down Future Strategy? Request Brochure Of Medical Image Analysis Software Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=56946

    The development of improved software for analysing medical images has assisted doctors and medical professionals in drawing apt diagnoses. Thenceforth, medical experts are emphasizing on widespread induction of medical imaging analysis software and systems. Advancements in radiology go hand in hand with the domain of medical imaging. The rising incidence of cardiovascular diseases and pulmonary disorders has generated humongous demand within the global medical imaging analysis software market. The medical fraternity is focusing on expediting the process of diagnosis and treatment. In order to accomplish this feat, it important to have a solid infrastructure for medical analysis and imaging.

    To Obtain All-Inclusive Information On Forecast Analysis Of Medical Image Analysis Software Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=56946

    Transparency Market Research (TMR) finds that the global medical imaging analysis software market would grow at a sound CAGR of 8.10% over the period between 2018 and 2026. The total value of the global medical imaging analysis software market would touch a value of US$ 5.4 Bn by 2026.

    Multiplicity of Applications for Medical Imaging to Propel Market Demand

    The need for improved imaging within the field of oncology and neurology has played an integral role in the growth of the global medical imaging analysis software market. Clinical research has emerged as a key area within medicine, and this factor has generated fresh revenues within the global market. Moreover, academic institutes and research projects are focusing on developing distinct technologies for medical imaging. High-incidence of urinary tract infections has necessitated the presence of premium technologies within nephrology. This is also a key standpoint from the perspective of growth within the global medical imaging analysis software market.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=56946

    Availability of 4D Imaging to Offer Key Opportunities for Vendors

    Until a decade ago, there was palpable scope for error within medical imaging, largely due to the absence of 3D and 4D imaging techniques. However, availability of 4D imaging techniques helps in conducting premium diagnosis across various domains within medicine. Furthermore, oncological treatments follow an in-depth route involving high-quality imaging. ContextVision is a leading medical technology software company recently developed an advanced medical imaging technique. The medical practitioners will be able interpret medical imaging with a greater level of deftness, using this software.

    Some of the key factors responsible for the growth of the global medical imaging analysis software market are Pie Medical Imaging, Media Cybernetics Inc., and Siemens Healthineers.

    More Trending Reports by Transparency Market Research –

    Reprocessed Medical Devices Market –

    https://www.globenewswire.com/news-release/2019/03/22/1759391/0/en/Reprocessed-Medical-Devices-Market-to-gain-revenue-worth-US-3-35-billion-by-2024-TMR.html

    Tissue Engineered Collagen Biomaterial Market –

    https://www.biospace.com/article/increasing-demand-for-regenerative-medicines-to-bolster-tissue-engineered-collagen-biomaterial-market/


  • Orthopedic Surgical Robots Market Foreseen to Grow Exponentially by 2026

    Orthopedic Surgical Robots Market: Snapshot

    Orthopedic surgical robots are created to help orthopedic surgeons perform surgeries. With the assistance of these robots, orthopedic operations can be carried out with improved accuracy and precision. Bone related minimally invasive surgeries can be executed through orthopedic surgical robots. Orthopedic surgical robots are usually small in size and are operated by healthcare experts for performing surgery. They help in steps where it requires fine movements such as surgeries treating for hip fracture, pubic rami, and pelvis surgery. These orthopedic surgical robots enhances the result of the surgery. It also makes the surgery reproducible, which is not possible by human hands.

    Report Overview @

    https://www.transparencymarketresearch.com/orthopedic-surgical-robots-market.html

    The global orthopedic surgical robots market is classified into region, application, product, and end-user, On the basis of product, the market is segmented as mako surgical system, ROBODOC surgical system, navio surgical system, and so on. As per the application, the global orthopedic surgical robots market can be classified into total hip replacement, partial knee replacement, complete knee replacement, and so on. On the basis of end-user, the orthopedic surgical robots market is segregated into orthopedic surgery centers, hospitals, ambulatory surgery centers, and so forth.

    Planning To Lay Down Future Strategy? Request Brochure Of Orthopedic Surgical Robots Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=53931

    Orthopedic Surgical Robots Market: Trends and Opportunities

    Rising cases of orthopedic ailments, for example, meniscus tear, ligament rupture, knee and hip fracture, rheumatoid arthritis, and osteoarthritis, and expanding demand for digitization in the medical industry, combined with shifting pattern toward the utilization of surgical robots in performing orthopedic medical procedures, are boosting the global orthopedic surgical robots market. Alongside this, advanced technology and increasing awareness among individuals with respect to the benefits of negligibly obtrusive orthopedic methods for surgical applications are driving the global orthopedic surgical robots market development.

    Nevertheless, mind-boggling expense related with medical procedure performed with the surgical robots and stringent government rules in regards to the utilization of robots for surgical objects are hindering the development of the global orthopedic surgical robots market. Besides, shortage of skilled experts to perform medical procedures with the assistance of surgical robots is estimated to moderate the market development.

    To Obtain All-Inclusive Information On Forecast Analysis Of Orthopedic Surgical Robots Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=53931

    Orthopedic Surgical Robots Market: Regional Outlook

    On the basis of geography, the global orthopedic surgical robots market is classified as Europe, North America, Asia Pacific, Latin America, and Middle East & Africa. Among these, North America region dominates the global orthopedic surgical robots market due rising cases of bone related ailments, along with increasing demand for automation in medical industry in the mentioned region. Besides, Europe held the maximum share of the global market because of rising inclination towards usage of surgical robots in several kinds of surgeries. It is well coupled with advancement in technologies in the robotics industry. Moreover, Asia Pacific region is flourishing significantly in orthopedic surgical robots market due to rising awareness with respect to the benefits of minimally invasive orthopedic robotic surgery instead of traditional orthopedic surgery. Also, rising elderly population along with the increase in world population are contributing in the development of the global orthopedic surgical robots market.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=53931

    Orthopedic Surgical Robots Market: Competitive Landscape

    The key players leading in the global orthopedic surgical robots market are Smith & Nephew plc, THINK Surgical, Inc., Depuy Sythes (JnJ), OMNI, Wright Medical Group N.V., MAKO Surgical Corp. (Stryker), Mazor Robotics (Medtronic), Intuitive Surgical, Hansen Medical (Auris Health, Inc.), and Medtech SA (Zimmer Biomet).

    More Trending Reports by Transparency Market Research –

    Strides in Medical Tourism Market –

    https://www.prnewswire.com/news-releases/strides-in-medical-tourism-market-key-driver-of-low-cost-patient-care-in-globalized-healthcare-systems-notes-tmr-301058469.html

    Clinical Laboratory Services Market -

    https://www.biospace.com/article/global-clinical-laboratory-services-market-to-expand-with-advancements-in-the-field-of-clinical-research/


  • RNA-based Therapeutics and Vaccines Market Estimated to Flourish by 2026

    Global RNA Based Therapeutics and Vaccines Market: Brief Account

    Global RNA based therapeutics and vaccines market is likely to experience a steep rise in its growth during the forecast period 2018- 2028, due to the rise in prevalence of chronic diseases such as diabetes, tuberculosis, cancer and certain other cardiovascular conditions. During the assessed period the market is predicted to expand at a whooping CAGR. Rapid advancement in technologies particularly in the healthcare sector has significantly lifted the demand for RNA based therapeutics and vaccines.

    Report Overview @

    https://www.transparencymarketresearch.com/rna-based-therapeutics-vaccines-market.html

    The global RNA based therapeutics and vaccines market could be classified on the basis of product type and indication type. The segment present in the report could be scrutinized based on the current trends, future potential, and several other testing factors.

    Authors of the report have taken the help of primary and secondary research which consists of information collected from various manufacturer and analysts. Authors have also taken the help of Porter’s five force model to bring a conclusion which might help in making profit in the industry as well as take important business steps to outplay other competitors in the market.

    Planning To Lay Down Future Strategy? Request Brochure Of RNA-based Therapeutics and Vaccines Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=49572

    Global RNA based Therapeutics and Vaccines Market: Rising Opportunities

    Healthcare sector have been bring their minds together to bring stability to the RNA molecules in the body with limited bioavailability. It is the RNA therapeutics which when combined with protein/lipid nanoparticles provide better stability. In spite of being in a clinical research phase the RNA therapeutics is been extensively explored with a primary aim to treat difficult diseases. One of the major factor which is driving the market is the rise of promising technologies such as antisense technology, SMaRT technology, and RNAi interference technology.

    Antisense technology and RNAi both are clasping the attention of research industry as these are used for providing base sequence to produce RNA drugs. Both the technology work in different way, for example RNAi technology works on by destructing specific mRNA molecules, whereas on the other hand antisense technology works by creating RNA strand from known gene sequence.

    However, there are several factors which are likely to stand straight on the way of market growth. Factors such as expensive research, high failure rated accompanied with problems faced in drug delivery are anticipated to bring down the RNA based therapeutics and vaccines market.

    To Obtain All-Inclusive Information On Forecast Analysis Of RNA-based Therapeutics and Vaccines Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=49572

    Global RNA based Therapeutics and Vaccines Market: Geographical Study

    On the basis of geography the global RNA based therapeutics and vaccines market is spread across Asia Pacific, LAMEA, Europe, and North America. Amongst the pack, North America holds the major share in the RNA based therapeutics and vaccines market due to fast adoption to technologies and rise in prevalence of chronic diseases. Other factors which are driving the RNA based therapeutics and vaccines market is the extensive research done in order to commercialize the therapeutics. Hefty investment done for research and advancement in RNA based technologies coupled with support provided by various government of this region is helping the market in the region to grow at a steady rate. However, it has been noticed that business dynamics present in Asia Pacific is expected to provide lucrative opportunity to leading players of this RNA based therapeutics and vaccines market owing to the less cost required for clinical research in comparison to North America and Europe

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=49572

    Global RNA based Therapeutics and Vaccines Market: Companies Mentioned

    Major players in the RNA based therapeutics and vaccines market are mostly focused on collaborating and partnering to keep up with the research activities against its competitors. Due to these collaboration, inventors are supplemented with financial resources and advanced technologies. Some of the major players in the market are Sylentis S.A., Moderena Therapeutics, Inc., mirage Therapeutics, Regulus Therapeutics, Inc., and Arbutus Biopharma Corp.

    More Trending Reports by Transparency Market Research –

    Cell Based Assays Market -

    https://www.prnewswire.com/news-releases/cell-based-assays-market-is-projected-to-collect-revenue-of-us19-710-7-million-by-2022--says-tmr-300810762.html

    Gastrointestinal Drugs Market -

    https://www.biospace.com/article/gastrointestinal-drugs-market-increasing-levels-of-stress-changing-lifestyles-and-unhealthy-eating-habits-to-drive-market/


  • DNA Polymerase Market to Witness an Outstanding Growth by 2025

    Global DNA Polymerase Market: Overview

    DNA polymerase is an enzyme which is necessary for assembling the nucleotides together on the DNA strand. DNA polymerase was discovered by Dr. Arthur Kornberg in 1955 in an E.coli cell. He had first discovered the DNA polymerase I. DNA polymerase is also an essential enzyme for DNA replication. With each cell division, DNA polymerase is required for the duplication of the cell’s DNA. It is through this that the genetic information is passed from one generation to the other. DNA polymerase functions by adding new nucleotide at the 3’ end of the new DNA strand. DNA polymerase also helps in correcting the mistakes in the new synthesized strand by the process known as ‘proofreading.’ In this process, incorrect coupling is recognized by DNA polymerase which then reverses its direction by one base pair. The incorrect part is further removed by the process called as excision. DNA polymerase is essential for the process of transcription and translation which results in protein synthesis.

    Report Overview @

    https://www.transparencymarketresearch.com/dna-polymerase-market.html

    Global DNA Polymerase Market: Drivers and Restraints

    There is a huge potential for the growth of the DNA polymerase market with the increasing incidence of cancer, neurological disorders, genetic mutation, and due to the increasing number of chronic diseases. According to WHO, the number of deaths due to cancer is expected to increase more than 70% over a decade. Also, increasing number of recombinant medicines for treating chronic diseases will drive the growth of the DNA polymerase market. Increasing crime across globe will boost the use of DNA polymerase in forensic testing such as DNA fingerprinting, which will drive the growth of the market. However, few restraining factors such as high cost, ethical issues, and stringent regulatory approval are likely to slow the growth of the DNA polymerase market.

    Planning To Lay Down Future Strategy? Request Brochure Of DNA Polymerase Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=41195

    Global DNA Polymerase Market: Key Segments

    The DNA polymerase market is segmented in terms of cell type, therapeutic application, according to the reagents used, end users, and geography. According to cell type, the DNA polymerase market is segmented into prokaryotes and eukaryotes. Prokaryotes are further segmented into DNA polymerase I, DNA polymerase II, DNA polymerase III, DNA polymerase IV, and DNA polymerase V. Based on Eukaryotes, the DNA polymerase market is further segmented into DNA polymerase α, δ and € and DNA polymerase γ. In terms of therapeutic application, DNA polymerase is used in treating cancer, neuro-generative diseases, genetic disorders, and also in forensic labs. Based on reagents used, the DNA polymerase market is segmented into antibodies, primers, buffers, and other reagents used. In terms of end users, the market is segmented into biotechnology companies, diagnostic centers, research institutes, and forensic laboratories.

    To Obtain All-Inclusive Information On Forecast Analysis Of DNA Polymerase Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=41195

    According to geography, the DNA polymerase market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the DNA polymerase market in terms of geography due to extensive research carried out in this region and also due to well-structured healthcare facilities with advanced treatments. Europe is the second largest market for DNA polymerase due to wide-ranging research activities carried out in this region with all major companies owning high stakes in the region. Increasing mergers and acquisitions with medical technology being widely used has facilitated the growth of the DNA polymerase market. Asia Pacific is a lucrative market backed by countries such as India, China, and Japan. Increasing interest of top players in this region due to improving economic conditions and developing healthcare infrastructure are the major drivers of the DNA polymerase market. Also, extensive research carried out in this region and growing awareness regarding genetic testing is an important factor for the growth of the market. Latin America, and Middle East & Africa are emerging markets and are expected to expand at a significant growth rate.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=41195

    Global DNA Polymerase Market: Key Players

    The top players in the DNA polymerase market are Novus, Excell Bio, Biomiga, Stratagene, SYGNIS, F. Hoffmann-La Roche Ltd, Finnzymes, Cyagen, Tiangen, Genetimes and others.

    More Trending Reports by Transparency Market Research –

    Invisible Orthodontics Market -

    https://www.prnewswire.com/news-releases/invisible-orthodontics-market-to-gain-us-7-259-6-million-by-2026--says-tmr-300809816.html

    Neurological Disorder Drugs Market -

    https://www.biospace.com/article/neurological-disorder-drugs-market-to-expand-at-a-cagr-of-5-percent-from-2019-to-2027/


  • Medical Glove Market Set for Rapid Growth and Trend, by 2030

    Medical Gloves: Introduction

    • Medical gloves are disposable or reusable gloves used during medical examination, cleaning, and surgical procedures to help prevent cross-contamination between caregivers and patients. These gloves are made from different types of polymer including nitrile rubber, latex, vinyl, and neoprene. Medical gloves are available in powdered or in non-powdered form.
    • Different types of medical gloves are available for different uses such as surgical gloves and examination gloves

    Report Overview @

    https://www.transparencymarketresearch.com/medical-glove-market.html

    Key Drivers of Global Medical Gloves Market

    • Increase in incidence of major chronic diseases, rise in awareness about safety & sanitation, stringent regulations about the usage of personal protective equipment (PPE), surge in number of hospitals in developing countries, and increase in incidence of hospital-acquired infection are projected to drive the global medical gloves market during the forecast period. An article published by the Global Antibiotic Resistance Partnership (GARP) stated that more than 190,000 neonatal deaths occur due to infections in India each year.
    • Increase in number of patients with coronavirus infection in countries such as the U.S., Italy, Spain, and India propels demand for medical gloves. Currently, in the U.S., around 2.5 million patients have tested positive for coronavirus. In India, around 474,587 people are suffering from coronavirus. These factors are anticipated to boost the growth of the global medical gloves market.

    Planning To Lay Down Future Strategy? Request Brochure Of Medical Glove Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=77687

    Latex Gloves to be Most Promising Segment

    • In terms of material, the global medical gloves market can be categorized into latex, nitrile, vinyl, and others
    • The latex segment accounted for the largest share of the global medical gloves market in 2019. The segment is expected to dominate the global market due to broad range of products available in the market and advantages over other type of gloves.

    Examination Gloves Segment to Witness Significant Growth

    • Based on product type, the global medical gloves market can be classified into examination gloves, surgical gloves, and chemotherapy gloves
    • The examination gloves segment accounted for the largest share of the global market in terms of revenue in 2019 and the trend is likely to continue during the forecast period. This can be attributed to increase in the number of patients with infectious diseases. According to the Centers for Disease Control (CDC), in the U.S., hospital-acquired infections account for an estimated 1.7 million infections and 99,000 associated deaths each year.

    To Obtain All-Inclusive Information On Forecast Analysis Of Medical Glove Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=77687

    Powdered Form to be Most Attractive Segment

    • In terms of form type, the global medical gloves market can be bifurcated into powdered form and non-powdered form. Powdered form was the largest segment in terms of revenue in 2019. The segment is projected to witness strong growth during the forecast period, as it helps to avoid the gloves from sticking to each other.

    Reusable Gloves to be Most Promising Segment

    • Based on usage, the global medical gloves market can be split into reusable and disposable. Reusable was the largest segment in terms of revenue in 2019. The segment is anticipated to witness strong growth during the forecast period due to advantages such as better protection, cost efficiency, reduction in medical waste, and increasing demand.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=77687

    Hospitals to be Most Attractive Segment

    • In terms of end-user, the global medical gloves market can be divided into hospitals, clinics, ambulatory surgical centers, diagnostics centers, and others. Hospitals was the largest segment in terms of revenue in 2019. The segment is expected to witness strong growth during the forecast period, as most of the surgical procedures and disease examinations are carried out in hospital setting.

    North America to Dominate Global Medical Gloves Market

    • In terms of region, the global medical gloves market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
    • North America dominated the global medical gloves market in 2019 and the trend is likely to continue during the forecast period. The region’s dominance can be attributed to increase in hospital-acquired infection, presence of major players, and well-established health care system.
    • The medical gloves market in Asia Pacific is anticipated to grow at a rapid pace during the forecast period owing to increase in adoption of new products and rise in demand for medical gloves in emerging countries such as India and China

    Key Players Operating in Global Medical Gloves Market

    The global medical gloves market was highly fragmented in 2019. Key players operating in the global market are:

    • Ansell Healthcare LLC
    • McKesson Corporation
    • Cardinal Health, Inc.
    • Medline Industries, Inc.
    • Top Glove Corporation Bhd
    • Dynarex Corporation
    • Kimberly-Clark Corporation
    • Hartalega Holdings Berhad
    • Semperit AG Holding
    • Others

    More Trending Reports by Transparency Market Research –

    Anti-Snoring Devices and Snoring Surgery Market -

    https://www.prnewswire.com/news-releases/anti-snoring-devices-and-snoring-surgery-market-to-touch-us22-7-billion-by-2024--says-tmr-300808446.html

    Hemophilia Treatment Drugs Market -

    https://www.biospace.com/article/fda-approvals-of-newer-drugs-bodes-well-for-hemophilia-treatment-drugs-market/


  • Patient Blood Management Market Outlook, Trend, Growth and Share Estimation Analysis

    Patient Blood Management Market: Introduction

    • Patient blood management (PBM) is a standard of care in the healthcare system, which offers to maximize the use of a patient’s own blood and avoid unnecessary blood transfusions during surgery. Patient blood management can also reduce the need for allogeneic blood transfusions and reduce health-care costs, while ensuring that blood components are available for patients who need them. It represents an international initiative in best practices for transfusion medicine that is supported by the World Health Organization (WHO).

    Report Overview @

    https://www.transparencymarketresearch.com/patient-blood-management-market.html

    Key Drivers and Restraints of Global Patient Blood Management Market

    • Increasing demand for donated blood is a major factor boosting the market. Increasing incidence of chronic diseases is boosting the demand for donation of blood. According to the American Cancer Society, more than 1.8 million people are expected to be diagnosed with cancer in 2020. Several of them are likely to need blood, sometimes daily, during their chemotherapy treatment. Sickle cell patients also require blood transfusions throughout their lives. As per The American National Red Cross, sickle cell disease affects 90,000 to 100,000 people in the U.S. and about 1,000 babies are born with the disease each year.

    Planning To Lay Down Future Strategy? Request Brochure Of Patient Blood Management Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=77625

    • However, high cost associated with automated systems is a key factor restraining the patient blood management market. A unit of blood usually costs about US$ 200 to US$ 300. There are added costs for storage and processing, as well as hospital and equipment fees. Costs can be much higher if the transfusion causes an infection or serious health issue. According to the study, when all activities involved in blood transfusion are considered, the estimated price of transfusion of one unit of red cells is between US$ 700 to US$ 1,200.

    Instrument Segment to Dominate Global Patient Blood Management Market

    • Based on product, the global patient blood management market can be divided into Instruments, accessories, reagents and kits, and software. The instruments segment can be further classified into blood processing devices, blood transfusion devices, blood culture screening devices, diagnostic & testing instruments, and blood storage devices. The blood processing devices subs-segment can be further split into centrifuges and blood cell processors. The blood transfusion devices segment can be further segregated into apheresis machines, plasma & plasma component separators, cell salvage systems, and other. The blood culture screening devices segment can be bifurcated into automated blood culture systems and supporting laboratory equipment. PCR Instruments, Hematology Analyzers, NGS Platforms, Blood Grouping Analyzers are the sub-segments of the diagnostic & testing instruments segment. The blood storage devices segment can be further divided into medical refrigerators and medical freezers. The accessories segment can be sub-segmented into syringes & needles, vials & tubes, blood bags, and other. Blood culture media, blood typing reagents, slide staining reagents, assay kits, and other are the sub -segments of the reagents and kits segment. The software segment can be split into blood bank management software, transfusion management software, and others.

    To Obtain All-Inclusive Information On Forecast Analysis Of Patient Blood Management Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=77625

    • Among all these, the instruments segment dominated the global market in 2019. Launch of technologically advanced products to smoothen the procedure of blood transfusion is a major factor boosting the market. In April 2019, Illinois-based Ecomed Solutions launched HEMAsavR, a blood management device that can be installed in operating theatres, to collect a patient’s lost blood during surgery and return it to their body.

    Whole Blood & Red Blood Cells Segment to Dominate Global Patient Blood Management Market

    • Based on components, the global patient blood management market can be divided into whole blood & red blood cells and plasma
    • The whole blood & red blood cells segment dominated the market in 2019, in terms of revenue generation. Whole blood contains red cells, stable clotting factors, and volume in each unit that make it potentially beneficial in rapidly hemorrhaging patients.
    • The World Health Organization has noted that road accidents are a major public health issue, as it injures about 50 million people a year, with 90% of such casualties occurring in developing countries.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=77625

    Blood Banks Segment to Expand Significantly

    • Based on end user, the global patient blood management market can be split into blood banks, hospitals and diagnostic clinics and & pathology labs
    • The blood banks segment accounted for a notable share of the patient blood management market in 2019. The segment is projected to expand at a notable CAGR during the forecast period. This expansion is attributed to a rise in the demand for blood transfusion along with an increase in awareness about blood donations.
    • Data reported to WHO shows significant increase of voluntary unpaid blood donations in low- and middle-income countries. An increase of 11.6 million blood donations from voluntary unpaid donors from 2008 to 2015 has been reported by 139 countries. The highest increase of voluntary unpaid blood donations has been witnessed the Southeast Asia (83%) and the Americas (70%).

    North America is estimated to dominate the Global Patient Blood Management Market

    • In terms of region, the global patient blood management market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
    • In terms of revenue, North America dominated the global patient blood management market followed by Europe. Increase demand for blood transfusion is a major factor that fuels the market. According to Community Blood Center, 4.5 million people in the U.S. are likely to need blood transfusion each year. According to WHO, of the 117.4 million blood donations collected globally, 42% of these are collected in high-income countries, home to 16% of the world’s population.
    • However, the market in Asia Pacific is estimated to expand at a considerable CAGR between 2020 and 2030. As per WHO data, in low-income countries, up to 52% of blood transfusions are given to children under 5 years of age; while in high-income countries, the most frequently transfused patient group is over 65 years of age, accounting for up to 75% of all transfusions.

    Key Manufacturers Operating in Market

    The global patient blood management market was highly fragmented in 2019. Key manufacturers operating in the global market are:

    • Haemonetics Corporation
    • Fresenius Se & Co. KGaA
    • Terumo Corporation
    • Immucor, Inc.
    • B. Braun Melsungen AG
    • Macopharma
    • Biomérieux SA
    • Asahi Kasei Medical Co. Ltd.
    • Kaneka Corporation
    • Bio-Rad Laboratories, Inc.
    • Abbott Laboratories
    • Grifols, S.A.
    • F. Hoffmann-La Roche LTD.
    • Livanova PLC
    • Danaher Corporation

    More Trending Reports by Transparency Market Research –

    Wheelchairs Market -

    https://www.prnewswire.com/news-releases/wheelchairs-market-to-surpass-a-value-of-us-6-253-6-million-by-2026--says-tmr-300805704.html

    Tele-Care Market -

    https://www.biospace.com/article/tele-care-market-to-witness-huge-growth-by-2025-ge-healthcare-abbott-laboratories-dexcom-inc-amd-global-telemedicine-inc-/


  • Catheter-related Bloodstream Infections Market to Set Phenomenal Growth by 2030

    Catheter-related Bloodstream Infections Market: Introduction

    • Catheter-related bloodstream infections occur due to presence of bacteremia. It is one of the most frequent, lethal, and costly complications of central venous catheterization and the most common cause of nosocomial bacteremia. It is caused due to an intravascular catheter by quantitative culture of the catheter tip or by differences in growth between catheter and peripheral venipuncture blood culture specimens.
    • Patient-related factors such as presence of distant infection, compromised integrity of the skin, granulocytopenia, and severity of illness increase the risk of bloodstream infection

    Report Overview @

    http://www.transparencymarketresearch.com/catheter-related-bloodstream-infections-market.html

    Key Drivers and Opportunities of Global Catheter-related Bloodstream Infections Market

    • Rise in prevalence of bloodstream infection is projected to drive the global market. An article published in Continuing Education in Anaesthesia, Critical Care & Pain stated that catheter-related bloodstream infections occur in ~3% of catheterizations; however, the incidence could be as high as 16%.
    • Serious effects associated with inaccurate diagnoses, such as procedural complications, lead to increase in morbidity and mortality. Hence, it is essential to make an accurate diagnosis of catheter-related bloodstream infections.

    Planning To Lay Down Future Strategy? Request Brochure Of Catheter-related Bloodstream Infections Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=77630

    • Moreover, hospital-acquired infection increases the risk of CRBSI. According to the International Journal of Critical Illness and Injury Science, CRBSI accounts for 10% to 20% of hospital-acquired infections in the U.K.
    • Governments in developing countries are making significant investments toward modernization of health care infrastructure, which is likely to increase access to health care. Moreover, health care-acquired infection is a major issue in developing countries. Hence, increase in demand for the products owing to surge in patient population presents significant opportunity in the global market.

    North America to Capture Major Share of Global Catheter-related Bloodstream Infections Market

    • North America is projected to account for major share of the global catheter-related bloodstream infections market during the forecast period due to well-established health care infrastructure. Europe is anticipated to be the second largest market from 2020 to 2030.
    • The catheter-related bloodstream infections market in Asia Pacific is expected to grow at a rapid pace during the forecast period owing to rise in prevalence of hospital-acquired infections. According to the World Health Organization Department of Communicable Disease, the risk of health care-associated infection is 2 to 20 times higher in developing countries than in developed countries.

    To Obtain All-Inclusive Information On Forecast Analysis Of Catheter-related Bloodstream Infections Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=77630

    Key Players Operating in Global Catheter-related Bloodstream Infections Market

    The global catheter-related bloodstream infections market is highly consolidated due to the presence of small number of key players. These players hold major share in their respective regions. Demand for catheter-related bloodstream infections products has increased in emerging as well as developed markets owing to rise in prevalence of blood stream infections. Growth strategies and focus on research & development by key players are the factors likely to drive the global catheter-related bloodstream infections market. For instance, in February 2020, CorMedix, Inc. announced that Neutrolin received grant from the U.S. Food and Drug Administration for the prevention of catheter-related blood stream infections (CRBSIs) in hemodialysis patients.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=77630

    More Trending Reports by Transparency Market Research –

    Urinary Catheters Market -

    https://www.prnewswire.com/news-releases/urinary-catheters-market-to-hit-us5-0-billion-by-2025--says-tmr-300806623.html

    Fecal Incontinence Market -

    https://www.biospace.com/article/fecal-incontinence-market-2017-expanding-in-worldwide-with-top-key-players-kimberly-clark-corporation-medline-industries-inc-/


  • Acute Hepatic Porphyria (AHP) Treatment Market Overview and Regional Outlook Study

    Global Acute Hepatic Porphyria (AHP) Treatment Market: Overview

    • Porphyrias are a set of metabolic disorders, each representing a defect in one of the eight enzymes in the heme biosynthetic pathway resulting in the accumulation of organic compounds called porphyrins. This leads to the clinical and biochemical profile typical for each porphyria. Hepatic porphyrias cause enzyme deficiency occurs in the liver.
    • Acute hepatic porphyria (AHP) is one of the types of hepatic porphyria. Porphyrias can be classified into acute or cutaneous. Cutaneous porphyrias are rare inherited metabolic disorders that cause blistering of the skin, pain, and/or redness and swelling in sun-exposed areas.

    Report Overview @

    https://www.transparencymarketresearch.com/acute-hepatic-porphyria-ahp-treatment-market.html

    • In people with genetic defect, one of the enzymes in the pathway that creates heme is deficient and causes increase in aminolevulinic acid synthase 1 in the blood and build up porphobilinogen throughout the body
    • Left untreated, acute porphyria attacks can result in respiratory failure, peripheral neuropathy, quadriplegia, life-threatening paralysis, irreversible neuronal damage, and death

    Planning To Lay Down Future Strategy? Request Brochure Of Acute Hepatic Porphyria (AHP) Treatment Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=77532

    Key Driver of Global Acute Hepatic Porphyria (AHP) Treatment Market

    • According to NCBI, the global prevalence of acute hepatic porphyria is projected to range from one in 500 to one in 50,000 individuals. In most regions, acute intermittent porphyria (AIP) is the most common, and ALA dehydratase-deficiency porphyria (ALAD) is the least common.
    • The prevalence of clinical AIP is reported to be 5 to 10 per 100,000 individuals, and the prevalence of genetic mutations of AIP is approximately one in 1675 individuals. This high rate of prevalence is likely to drive the demand for treatment of acute hepatic porphyria.

    To Obtain All-Inclusive Information On Forecast Analysis Of Acute Hepatic Porphyria (AHP) Treatment Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=77532

    North America to Account for Major Share of Global Acute Hepatic Porphyria (AHP) Treatment Market

    • In terms of region, the global acute hepatic porphyria (AHP) treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global market during the forecast period.
    • North America is anticipated to account for significant share of the global market due to well-defined reimbursement policies from public and private health insurance firms that help provide patients easy access of diagnosis and extensive research & development activities. In the U.S., approximately 5,000 people experience one or more of acute hepatic porphyria attacks annually.
    • Asia Pacific is expected to account for substantial share of the market in terms of revenue during the forecast period due to increase in patient population

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=77532

    Key Players Operating in Global Acute Hepatic Porphyria (AHP) Treatment Market

    Major players operating in the global acute hepatic porphyria (AHP) treatment market are:

    • Alnylam Pharmaceuticals, Inc.
    • Lundbeck A/S
    • Alleviare Life Sciences Pvt. Ltd.
    • Other Prominent Players

    More Trending Reports by Transparency Market Research –

    Legionella Testing Market -

    https://www.globenewswire.com/news-release/2019/03/29/1788547/0/en/Legionella-Testing-Market-to-reach-a-value-of-US-398-7-million-by-2025-TMR.html

    Arbovirus Diagnostic Tests Market -

    https://www.biospace.com/article/global-arbovirus-diagnostic-tests-market-to-gain-from-rising-incidence-of-arbovirus-diseases-and-recent-technological-advancements-says-tmr/


  • Hib Vaccine Market Foreseen to Grow Exponentially by 2030

    Global Hib Vaccine Market: Introduction

    • Haemophilus influenza type b (Hib) is a bacterium which causes several diseases such as pneumonia, epiglottitis, meningitis, and sepsis mostly in children younger than 5 years
    • In infants and young children, Hib disease can cause serious health issues. Infection can spread to different parts of the body — including the brain, throat, spinal cord, and lungs. These infections can even cause serious implication on child’s health; they can be deadly. For example, Hib meningitis causes brain damage or hearing loss in 1 in 5 children who survive it.

    Report Overview @

    https://www.transparencymarketresearch.com/hib-vaccine-market.html

    • The Hib vaccine is the best way to protect the child from Hib disease
    • Two types of vaccines are available that can be used against Hib disease:
      • The Hib vaccine protects children and adults from Hib disease
      • The DTaP-IPV/Hib vaccine protects babies ranging from 2 to 18 months from Hib disease, tetanus, diphtheria, whooping cough, and polio

    Planning To Lay Down Future Strategy? Request Brochure Of Hib Vaccine Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=77444

    Key Drivers of Global Hib Vaccine Market

    • Numerous initiatives taken by governments and private organizations, for example, GAVI combined with the WHO activity to present the haemophilus influenzae type B disease into global immunization programs, are expected to drive the market. Because of the initiative, 80% of the GAVI covered countries have effectively provided the vaccine. These initiatives helped provide immunization to low income countries at a nominal rate, because of which these vaccines are made accessible worldwide.
    • The different initiatives taken up by organizations in the healthcare sector to give better medicines coupled with research and development are anticipated to add to the growth of the market during the forecast period
    • According to the American Medical Association, due to Hib, approximately 30,000 deaths occur in children aged between 1 to 23 months. The mortality rate caused by Hib is likely to drive the demand for Hib Vaccine, as the vaccine is the best way to protect the infants and young children from infection.

    To Obtain All-Inclusive Information On Forecast Analysis Of Hib Vaccine Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=77444

    Restraints of Global Hib Vaccine Market

    • High prices of vaccine are projected to hamper the growth of the global Hib vaccine market. For example, average cost of DTap-IP-HI vaccine is US$ 96. Prices can vary from $50 to $200 per vaccine. The high price is expected to hinder the growth of the market in the emerging economies, especially those countries which are not a part of international initiatives.
    • These vaccines have limited shelf life, combined with explicit storage conditions for containing these liquid monovalent Hib vaccines that cannot be permitted to freeze, simultaneously should be stored in temperatures between 2?C to 4?C
    • Additionally, patients may have hypersensitivity to certain substances that is anticipated to decrease the demand and is assessed to restrain the market in the next few years

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=77444

    North America to Lead Global Hib Vaccine Market

    • In terms of region, the global Hib vaccine market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
    • North America dominated the global Hib vaccine market, owing to large investment in healthcare sector and continuous research & development. Increase in government initiated vaccination program is expected to fuel the growth of the Hib vaccine market in North America.
    • Europe is the second largest market for Hib vaccination due to high adoption of the immunization. Almost all the member countries of Europe have implemented Hib vaccine as a part of infant immunization program.
    • The market in Asia Pacific is expected to grow at a high pace during the forecast period due to rise in adoption of vaccine and increased awareness of immunization. A few countries such as China and India are involved in developing vaccines.
    • Regions such as Latin America and Middle East & Africa are anticipated to be lucrative markets for Hib vaccine during the forecast period due to various international initiatives taking place and upgraded health care facilities

    Key Players Operating in Global Hib Vaccine Market

    • GlaxoSmithKline plc
    • Sanofi
    • Merck Sharp & Dohme Corp
    • Takeda Pharmaceutical Company Limited
    • Novartis AG
    • Bharat Biotech
    • Serum Institute of India Pvt. Ltd
    • BIO-MED
    • Panacea Biotec Ltd
    • LG Chem
    • Biological E Limited

    More Trending Reports by Transparency Market Research –

    Thoracic Drainage Devices Market -

    https://www.prnewswire.com/news-releases/global-thoracic-drainage-devices-market-to-accumulate-revenues-worth-us-980-mn-by-2027-expanding-at-a-cagr-of-5-over-2019-2027-transparency-market-research-301022829.html

    Prostate Cancer Therapeutics Market -

    https://www.biospace.com/article/prostate-cancer-therapeutics-market-is-projected-to-expand-at-a-cagr-of-8-percent-from-2019-to-2027/


  • Immune-mediated Inflammatory Disease (IMID) Treatment Market

    Immune-mediated Inflammatory Diseases: Introduction

    • Immune-mediated inflammatory disease (IMID) is a group of unrelated conditions that lack a definitive etiology, but share a common inflammatory pathway leading to inflammation. Immune-mediated diseases are conditions triggered by over activity or abnormal activity of the body’s immune system. All immune-mediated inflammatory diseases (IMID) can cause organ damage, and are associated with increased morbidity and/or mortality.

    Report Overview @

    https://www.transparencymarketresearch.com/immune-mediated-inflammatory-disease-treatment-market.html

    • The normal immune system is a complex system that protects our bodies from infections. The white blood cells or lymphocytes help us fight the infection when our body becomes infected with a bacteria, virus, or parasite.
    • Some of the well-known immune-mediated inflammatory or autoimmune diseases include ankylosing spondylitis, psoriasis, psoriatic arthritis, Crohn's disease, Behcet's disease, arthritis, inflammatory bowel disease (IBD), systemic lupus erythematosus, insulin-dependent (type 1) diabetes mellitus, and various allergies (eczema, hives, hay fever, asthma attacks, food allergies, etc.), as well as many cardiovascular, neuromuscular, and infectious diseases

    Planning To Lay Down Future Strategy? Request Brochure Of Immune-mediated Inflammatory Disease (IMID) Treatment Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=77629

    Key Drivers and Restraints of Global Immune-mediated Inflammatory Disease Treatment Market

    • The number of people affected with autoimmune diseases is rising consistently across the world. The root cause of a number of these diseases can be traced to a lack of healthy lifestyle and dietary habits and genetics that can trigger these diseases. Rise in the number of these diseases propels the global immune-mediated inflammatory disease treatment market.
    • Cardiovascular and respiratory diseases have affected a large number of individuals globally, and are the leading cause of death among the global population
    • Increase in incidence of chronic diseases of the liver, heart, kidneys, pancreas, and blood disorders have augmented the demand for immune-mediated inflammatory disease treatment. Therefore, a rise in the incidence of autoimmune diseases across the globe fuels the global immune-mediated inflammatory disease treatment market.
    • However, lack of patient awareness, side effects associated with drugs, and poor reimbursement is anticipated to hamper market growth during the forecast period

    To Obtain All-Inclusive Information On Forecast Analysis Of Immune-mediated Inflammatory Disease (IMID) Treatment Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=77629

    Asthma and COPD to Lead Global Market

    • The global immune-mediated inflammatory disease treatment market can be segmented based on treatment type, indication, distribution channel, and region
    • In terms of treatment type, the global immune-mediated inflammatory disease treatment market can be classified into traditional drugs (corticosteroids, non-steroidal anti-inflammatory drugs, anti-TNF agents, etc.), targeted biologic therapies, and novel therapies. Based on indication, the global market can be categorized into asthma, chronic obstructive pulmonary diseases (COPD), inflammatory bowel disease (IBD), systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), psoriasis, and others. In terms of distribution channel, the global immune-mediated inflammatory disease market can be divided into hospital pharmacies, retail pharmacies, and online pharmacies.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=77629

    Asia Pacific to be Lucrative Market for Immune-mediated Inflammatory Disease Treatments

    • The global immune-mediated inflammatory disease treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
    • Adoption of advanced treatment options is increasing in developing countries, thereby providing opportunities in the global immune-mediated inflammatory disease treatment market
    • Availability of superior treatment facilities at quite low prices in developing countries, such as India and China, compared to that in the West is a major factor boosting the immune-mediated inflammatory disease treatment market in Asia Pacific. Growing medical tourism industry in developing countries is anticipated to offer significant opportunities in the immune-mediated inflammatory disease treatment market in the region.

    Key Players Operating in Global Immune-mediated Inflammatory Disease Treatment Market

    Leading players in the global immune-mediated inflammatory disease treatment market include:

    • GlaxoSmithKline
    • Eli Lilly and Company
    • AstraZeneca
    • Bristol-Myers
    • Sanofi SA
    • Roche

    More Trending Reports by Transparency Market Research –

    Bone Densitometers Market -

    https://www.prnewswire.com/news-releases/bone-densitometers-market-to-reach-us-1-11-bn-by-2024--rising-cases-of-osteoporosis-to-drive-demand--tmr-300816933.html

    Vascular Access Devices Market –

    https://www.biospace.com/article/vascular-access-devices-market-high-incidence-of-chronic-diseases-fuels-demand/


  • Plasma Protein Therapeutics Market Estimated to Record Highest CAGR by 2027

    Transparency Market Research (TMR) has published a new report titled, ‘Plasma Protein Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the Plasma Protein Therapeutics Market was valued at US$ 22,413.9 Mn in 2018 and is projected to expand at a CAGR of 7.0% from 2019 to 2027.

    Overview

    • Plasma-derived therapies and their recombinant analogs, collectively referred to as plasma protein therapies, are unique, biologic medicines, versus synthetic or chemical medicines, because production begins with plasma, a biologic starting material.
    • Stringent Regulations and Reimbursement Issues, diagnosis rate, public awareness and high price of the biological are the major market barrier. High demand in plasma protein therapeutic proteins and medicinal use in new indications, penetration of existing indications, better access to medicines in emerging markets, aging population, and new plasma-derived therapies are likely to drive the market.
    • North America is poised to cover a high share in 2018, while Asia Pacific is poised to grow at a highest CAGR in the forecast. The growth of plasma derived market in North America is mainly due to increasing IVIG sales during the forecast period. There is a growing demand of Albumin in Asia Pacific market, followed by Latin America.

    Planning To Lay Down Future Strategy? Request Brochure Of Plasma Protein Therapeutics Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10424

    Growing Investment in Innovation, Rising Demand for Immunoglobulin (IG) and Rising Indications and Therapeutic use of Plasma Derived Protein Therapeutics to Drive Market

    • The plasma protein industry has been investing in research and development of new plasma proteins therapies (e.g.: Ceruloplasmin, IgA, Plasmin) leading to innovative treatments for the benefits of patients. In March 2016, Grifols announced that it will invest US$ 360 Mn to expand its production capabilities for plasma-derived therapies. The investment will increase the plasma fractionation capacity and purification of several proteins. Thus this factors drive the growing investment in innovation.
    • Plasma-derived IG is used for a wide range of autoimmune and inflammatory diseases. Increased recognition and treatment of immune deficiencies in developing world have added to the global demand for IG. However, increased use of high dose therapy, particularly in autoimmune neurologic diseases is the major reason for the continued strong growth in demand for IG products. Thus this factors drive the demand for immunoglobulin.
    • Plasma protein therapies are used in the treatment of rare diseases. The therapies include: Immunoglobulin's used to treat a number of diseases in individuals with immune deficiencies and autoimmune diseases, Clotting-factor therapies used for individuals with hemophilia A and B and other bleeding disorders, Albumin, which is used in acute settings to treat individuals with shock, trauma, burns and other conditions. Thus this factors drive the plasma protein therapeutics and their uses.

    To Obtain All-Inclusive Information On Forecast Analysis Of Plasma Protein Therapeutics Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=10424

    Immunoglobulin Segment to Dominate Market

    • Based on product type, the Plasma Protein Therapeutics Market has been divided into Immunoglobulin, Albumin, Coagulation Factor, C1-esterase inhibitors and others. The Immunoglobulins are plasma derived molecules, which account for a major share of the plasma derived protein products market. Intravenous immunoglobulin (IVIG) is a major product derived from large pools of human plasma containing antibodies against a broad spectrum of bacterial and viral agents. High global demand for IVIG is due to increased usage in primary immunodeficiency and neurological applications. The Immunoglobulins segment dominated the Plasma Protein Therapeutics Market in 2018 and the trend is projected to continue during the forecast period.

    Hereditary Angioedema to be Highly Lucrative Segment

    • In terms of applications, the Plasma Protein Therapeutics Market has been classified into Hemophilia, "Primary Immunodeficiency Disorder (PID)", "Idiopathic Thrombocytopenic, Purpura", Secondary Immunodeficiency, Hereditary Angioedema, Other applications.
    • Hereditary angioedema (HAE) is a rare disorder caused by C1 esterase inhibitor deficiency. It accounts for only 2% of clinical angioedema cases. In type 1 and type 2 cases of hereditary angioedema, the former is the 85% of the cases. The worldwide incidence of HAE is approximately 1 in 30,000 to 50,000 persons. Growing awareness and treatment rate is expected to drive the segment.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=10424

    North America to Dominate Global Market

    • In terms of region, the Plasma Protein Therapeutics Market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the Plasma Protein Therapeutics Market in 2018, followed by Europe.
    • The immunoglobulin segment accounted for the largest share of the market in North America in 2015. The C1 esterase inhibitors segment is poised to expand at a high CAGR, followed by the albumin segment during the forecast period. The coagulation factor (VIII and IX) segment would decline at a CAGR of 7.8% due to increasing trend in usage of recombinant proteins and rising FDA approvals.
    • Albumex and Buminate are the key brands in North America. Increasing therapeutic usage in new indications such as cirrhosis, acute liver failure, and amyotrophic lateral sclerosis is likely to drive the market. Moreover, the FDA approval for capacity expansion is expected to propel the market. For instance, CSL Ltd. received FDA approval for Albumin capacity expansion in Kankakee, U.S. that would automatically increase production, thus boosting market growth in the U.S.

    Competitive Landscape

    • The Plasma Protein Therapeutics Market is fragmented in terms of number of players. Key players in the global market include Baxter International, Biotest, CSL Behring, GRIFOLS, S.A., Kedrion, Octapharma USA, Inc., Shire Plc., China Biologics and among others

    More Trending Reports by Transparency Market Research –

    Geriatric Medicines Market –

    https://www.prnewswire.co.uk/news-releases/rising-incidence-of-chronic-disorders-in-elderly-to-drive-demand-within-the-global-geriatric-medicines-market-tmr-891385678.html

    Glioblastoma Multiforme Treatment (GBM) Market –

    https://www.biospace.com/article/glioblastoma-multiforme-treatment-gbm-market-rise-in-awareness-regarding-cancer-and-novel-therapies-to-boost-the-market/


  • Molecular Diagnostics Market Size will Observe Substantial Growth by 2025

    The global molecular diagnostics market is witnessing a significant growth since past few years. The market is likely to register a consolidated competitive scenario in the span of coming years, says an analyst at TMR. The three players leading the market collectively with an aggregated share of 54.0% in 2015 are F. Hoffmann-La Roche AG, Abbott Laboratories, and Danaher Corporation. Various well established firms are investing heavily in the research and development activities, to improve the functionalities of molecular diagnostics tools. The major players are concentrating on improving their product portfolios and are working on key business strategies such as mergers and acquisitions to fortify their presence in the market.

    According to the report by Transparency Market Research (TMR), the global molecular diagnostics market is estimated to project a sound CAGR of 11.6% within the forecast period from 2016 to 2025. In 2015, the global molecular diagnostics market was valued around worth of US$7.1 bn. This market figure is anticipated to reach a valuation worth about US$18.9 bn by the end of forecast period.

    Planning To Lay Down Future Strategy? Request Brochure Of Molecular Diagnostics Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1783

    In terms of technology, the global molecular diagnostics market is classified as hybridization, polymerase chain reaction and real-time polymerase chain reaction, transcription-mediated amplification, microarray, and next-gen sequencing. Among these, the PCR segment held the highest share of 39.1% of entire molecular diagnostics market in 2016. This rising demand is attributed to affordability of the PCR segment. Geographically, North America region led the global molecular diagnostics market with a major share of 39.1%. This lead is credited to the rising cases of contagious diseases in the region. Besides, the government is also taking several initiatives to make masses aware about the technology, propelling the additional growth rate in the regional market.

    To Obtain All-Inclusive Information On Forecast Analysis Of Molecular Diagnostics Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1783

    Rising Cases of STDs to Support Demand in Market

    With the advent of biomarkers for unfaltered prognosis of chronic ailments such as hepatitis and HIV, the demand in global molecular diagnostics market is also foreseen to get boost. Moreover, increasing research and developmental activities behind the expansion of biomarkers in developed and developing nations is another factor contributing towards the growth of molecular diagnostics market.

    The rising prevalence of STDs, Chlamydia trachomatis and Neisseria gonorrhea that calls for an urgent need of diagnosis of these diseases. In the span of coming years, this is majorly expected to support a rising demand in the molecular diagnostics market. Also, the market growth is also backed consistently by the comfort and simplicity provided to the clinicians. In addition, upgraded biomarker have even reduced the computational time of usual complex stages.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1783

    Poor Reimbursement Policies to Hamper Market Growth

    The revenue growth in the global molecular diagnostics market is estimated to be hindered by the delay in approval from FDA and similar administrative bodies. This has resulted in the decline in demand for molecular diagnostics devices in the global market. Furthermore, lack of proper reimbursement policies has also brought down the otherwise progressive growth rate of molecular diagnostics market.

    However, the decline in demand can be picked up by improving the quality of personalized treatments in several developed countries. Besides, electrifying growth in healthcare sector in the regions is likely to pump the market development as well in coming years.

    More Trending Reports by Transparency Market Research –

    Sterilization Services Market –

    https://www.prnewswire.com/news-releases/outbreak-of-covid-19-to-boost-the-growth-of-global-sterilization-services-market-during-the-tenure-of-2019-to-2027-tmr-301062487.html

    Clostridium Vaccine (Animal Health) Market –

    https://www.biospace.com/article/clostridium-vaccine-animal-health-market-large-demand-of-pork-to-boost-the-growth-of-swine-segment/


  • Catheters Market Value Projected to Expand by 2025

    The vendor landscape in the global catheters market is characterized by high degree of consolidation: a few companies with technological expertise and financial might have established their dominance. Several of them have ramped up their investments to reinforce some of the aggressive branding moves. Financial might has also helped them not let their funding flows to dry up in research and development, helping them meet strict requirements in testing, production, and design. This has also caused to elevate the barrier to entry. They have also been stressing on improving the outcomes by improving the design parameters. Manufacturers are also trying to address the patient concerns while improvising on designs.

    Some of the well-entrenched players in the global catheters market are Cook Group, Teleflex Incorporated, Johnson & Johnson, Boston Scientific, C.R. Bard Inc., Medtronic Plc., and B. Barun Melsungen AG.

    Planning To Lay Down Future Strategy? Request Brochure Of Catheters Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=109

    In coming years during the forecast period, the focus on constant material and technological advancement is expected to define the contours of competition in the catheters market. Top contenders for unveiling innovative catheters are testing new elastomer materials that have several mechanical properties to meet the end-user demand.

    Health Burden of Cardiovascular Diseases Drive Demand for Catheterization Techniques

    Opportunities in the global catheters market have thrived mainly on the sales of intravenous medical devices and vascular access devices. Their uptake in the health care industry has been rising due to the use of catheters in a wide range of diagnostic and therapeutic applications.

    The global catheters market is expected to garner CAGR of 7.4% from 2017 to 2025. By 2025 end, the valuation is expected to reach US$55,985.1 million.

    To Obtain All-Inclusive Information On Forecast Analysis Of Catheters Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=109

    Among the various product types, cardiovascular catheters are expected to contribute the dominant share in global catheters market. In the light of high mortality and health burden of cardiovascular diseases, the drive for use of cardiovascular catheters among patient population has risen. Rising incidence of urinary tract procedures is bolstering growth in the catheters market.

    Both ambulatory services and hospitals are witnessing the rise in uptake of intravenous access devices, spurring revenue growth in the catheters market. Advancements in cardiac catheterization techniques have helped expand the popularity of new technologies in catheters in these healthcare settings. These technologies focus on minimizing the risk of catheter-associated risks. Rapid advances have also been made in urinary catheters, unlocking new prospects in the catheters market.

    Adoption of Cutting-Edge Intravenous Medical Devices Account for Opportunities in North America

    Of all the regional markets, North America holds the major share. Europe is one of the prominent regions for revenue generation in the catheters market. Both key regional markets have seen the rapid uptake of advanced catheterization technologies. Adoption of cutting-edge intravenous medical devices and vascular access devices in healthcare systems has spurred revenue in the catheter market.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=109

    On the other hand, Asia Pacific is expected to offer substantial, consistent revenues in the catheters market. Rise in medical tourism has spurred opportunities in the regional market. Rising elderly population in numerous countries has bolstered the demand for minimally invasive medical technologies. This has spurred the demand for new technologies in the catheter market. Furthermore, growing efforts of governments to reduce the hospital expenses has also propelled the uptake of catheterization procedures for urinary and cardiac conditions. Rising incidence of cardiovascular treatments is expected to boost the market.

    More Trending Reports by Transparency Market Research –

    Strides in Medical Tourism Market –

    https://www.prnewswire.com/news-releases/strides-in-medical-tourism-market-key-driver-of-low-cost-patient-care-in-globalized-healthcare-systems-notes-tmr-301058469.html

    Platelet Incubator Market –

    https://www.biospace.com/article/platelet-incubator-market-favorable-government-initiatives-to-promote-platelet-incubator-to-boost-growth/


  • Multiple Sclerosis Drugs Market Size Estimated to Observe Significant Growth by 2027

    Multiple Sclerosis Drugs Market: Introduction

    In terms of revenue, the multiple sclerosis drugs market is projected to expand at a CAGR of ~6% during the forecast period, due to numerous factors, about which TMR offers comprehensive insights and forecasts in the global multiple sclerosis drugs market report.

    Multiple sclerosis is a central nervous system disorder. It is a potentially disabling disease of the spinal cord and brain. In multiple sclerosis, the immune system attacks the myelin (protective sheath) that shields nerve fibers, which causes communication issues between the brain and the rest of the body. Multiple sclerosis can cause permanent deterioration or damage to the nerves. The cause of multiple sclerosis is still unknown. Researchers believe that genetic and environmental factors contribute to the risk of developing multiple sclerosis.

    Rise in prevalence and incidence of multiple sclerosis, rapid increase in the geriatric population leading a surge in cases of multiple sclerosis, and increase in awareness about multiple sclerosis are the major factors fueling the growth of the multiple sclerosis drugs market.

    Planning To Lay Down Future Strategy? Request Brochure Of Multiple Sclerosis Drugs Market

    https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1130

    Use of Monoclonal Antibodies for Treatment of Multiple Sclerosis

    In terms of drug class, the multiple sclerosis drugs market has been segmented into interferon beta, sphingosine 1 phosphate receptor modulators, mixed polymers, NF-κB inhibitor, pyrimidine synthesis inhibitor, monoclonal antibodies, corticosteroids, adrenocorticotropic hormone, and others. The interferon beta segment accounted for a major share of the multiple sclerosis drugs market in 2018. Interferon beta is a cytokine in the interferon family that is used to treat multiple sclerosis. Interferons are proteins produced by the human body. Interferon beta drugs include Avonex, Betaseron, Extavia, Rebif, and Plegridy. However, the monoclonal antibodies segment is expected to dominate the multiple sclerosis drugs market during the forecast period. Dominance of the segment can be attributed to the launch of new monoclonal antibody products for the treatment of multiple sclerosis, including Ofatumumab and Ublituximab, during the forecast period.

    High Prevalence of Relapsing-remitting MS (RRMS)

    In terms disease type, the multiple sclerosis drugs market has been segmented into relapsing-remitting MS (RRMS), primary-progressive MS (PPMS), secondary-progressive MS (SPMS), and progressive-relapsing MS (PRMS). The segment is expected to dominate the global market during the forecast period, due to large patient pool with RRMS. About 75% to 85% of population suffering from MS have relapsing-remitting MS (RRMS).

    To Obtain All-Inclusive Information On Forecast Analysis Of Multiple Sclerosis Drugs Market , Request A Discount

    https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1130

    Preference for Parenteral Route of Administration for Drugs

    In terms of route of administration, the multiple sclerosis drugs market has been bifurcated into parenteral and oral. The parenteral segment dominated the multiple sclerosis drugs market in terms of share in 2018. The segment is expected to dominate the market during the forecast period. More than 60% of multiple sclerosis drugs are in injectable form. Moreover, launch of injectable drugs, such as Ocrevus, Cladribine, and Ofatumumab, and increase in usage of these drugs for the treatment of multiple sclerosis are likely to drive the segment during the forecast period.

    Retail Pharmacies & Drug Stores to be Preferred Distribution Channel

    Based on distribution channel, the multiple sclerosis drugs market has been categorized into hospital pharmacies, retail pharmacies & drug stores, and online pharmacies. The retail pharmacies & drug stores segment is projected to constitute significant share of the multiple sclerosis drugs market by 2027. Large share of the segment can be attributed to easy availability of multiple sclerosis drugs at retail pharmacy stores and large number of retail pharmacy stores in the U.S., Europe, and developing countries. Increase in the number of retail pharmacy store chains in developing as well as developed countries is anticipated fuel the growth of the segment during the forecast period.

    Request For Covid19 Impact Analysis –

    https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1130

    Multiple Sclerosis Drugs Market: Prominent Regions

    North America to Create High Incremental Opportunity

    In terms of revenue, North America is projected to dominate the multiple sclerosis drugs market from 2019 to 2027. This can be ascribed to higher sales of multiple sclerosis drugs in countries such as the U.S. and Canada. Moreover, rise in prevalence of multiple sclerosis in the region and favorable medical reimbursement policies in the U.S. and Canada drive the market in North America. However, the multiple sclerosis drugs market in Asia Pacific is expected to expand at a relatively high CAGR during the forecast period. The multiple sclerosis drugs market in Asia Pacific is driven by a large pool of patients with multiple sclerosis in China and Japan, approval and launch of new products, and rise in investments by leading players in the region in therapeutic drugs for multiple sclerosis disease.

    New product launches in China and Japan and rigorous marketing campaigns adopted by leading players in order to gain competitive advantage are anticipated to augment the market in Asia Pacific during the forecast period. However, patent expiry of top branded drugs in Japan is expected to hamper the growth of the market in the country from 2018 to 2020.

    Strategic Collaborations, Investments, and Launch of New Products to Drive Market

    The report provides profiles of leading players operating in the multiple sclerosis drugs market. Bayer AG, Teva Pharmaceutical Industries Ltd., Novartis AG, Sanofi, F. Hoffmann-La Roche Ltd., Celgene Corporation, Acorda Therapeutics, Inc., Biogen, Inc., Actelion Pharmaceuticals (Johnson & Johnson), EMD Serono (Merck KGaA), and AbbVie, Inc. are the major players operating in the global multiple sclerosis drugs market. These players have adopted strategies such as strategic collaborations, launch of new products, and investments to increase share and presence in the multiple sclerosis drugs market.

    • For instance, in June 2019, the U.S. Food and Drug Administration (FDA) accepted Celgene’s New Drug Application (NDA) for ozanimod for the treatment of people with relapsing form of multiple sclerosis (RMS) in the U.S.
    • Additionally, the European Medicines Agency (EMA) accepted Marketing Authorization Application (MAA) of ozanimod for the treatment of adults with relapsing-remitting multiple sclerosis (RRMS) in the European Union
    • In January 2019, Biogen, Inc. and Skyhawk Therapeutics, Inc. entered into a strategic collaboration. According to the terms of the agreement, the companies will leverage Skyhawk Therapeutics’ SkySTAR technology platform for the development of innovative small molecule treatments for neurological diseases including multiple sclerosis and spinal muscular atrophy.

    More Trending Reports by Transparency Market Research –

    Cell Based Assays Market -

    https://www.prnewswire.com/news-releases/cell-based-assays-market-is-projected-to-collect-revenue-of-us19-710-7-million-by-2022--says-tmr-300810762.html

    Hematocrit Test Devices Market –

    https://www.biospace.com/article/hematocrit-test-devices-market-integrated-devices-to-open-new-opportunities-in-the-market/


connect